First half of 2019 Canadian VC set a torrid pace, with 264 financings completed totaling $2.9 billion, on pace to pass $5B mark for first time since 2000Read More →
Chinook Therapeutics secured US $65M Series A funding led by Versant Ventures with participation of seed investor Apple Tree Partners and new investor Samsara BioCapital.
Read More →
CPE Media Analytics released comprehensive results for initial public offerings (IPOs) for the first half of 2019.Read More →
92 law firms worked on 525 financings with total deal value of $14.76B in Q1. Owen Bird Law Corporation Norton Rose Fulbright Canada LLP led in deal numbers and total deal valueRead More →
Canaccord Genuity Corp. and Greybrook Securities Inc. the leading investment dealer and EMD respectively in Q1 exempt financing fees earned. Read More →
US investors invested $6.03 billion, accounting for 61% of $10 billion disclosed cannabis investments, almost doubling of the total amount by Canadian investors ($3.1 billion)Read More →
Ontario cannabis and related companies received lion’s share of cannabis investments. US and companies with major US operations captured increasing share of investments with $3.64B (23%)Read More →
The CSE most active exchange in Canada leading with 349 cannabis and related deals for $4.65B (29% of the $16 billion total)Read More →
Cannabis and related companies raised $16 billion in 2018, 445% increase over 2017 and 2,117% over 2016. Read More →
Canadian VC/PE backed IPOs overwhelmingly underperformed against US VC/PE backed IPOs and VC backed IPO underperformed PE Backed IPOs, CPE Media Analytics report foundRead More →
The last business day before Christmas was the busiest financing closing day with the closing of 53, 86 and 75 financings respectively in 2016, 2017 and 2018.Read More →
US VCs invested $439M, 2.7 times of the $162M invested by Canadian VCs. International CVCs invested $120M, ranking 3rd behind US VCs and Canadian VCs.Read More →
